pilocarpine has been researched along with Weight Loss in 3 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study aims at investigating AO effects on (i) latency to first seizure, seizure severity, weight loss, mortality rate, (ii) lipid peroxidation level, nitrite level, and catalase activity in the hippocampus after SE induced by pilocarpine (PC)." | 7.88 | Anticonvulsant effect of argan oil on pilocarpine model induced status epilepticus in wistar rats. ( Ammouri, H; Bahbiti, Y; Berkiks, I; Bikjdaouene, L; Chakit, M; Hessni, AE; Mesfioui, A; Nakache, R; Ouichou, A, 2018) |
| " This study aims at investigating AO effects on (i) latency to first seizure, seizure severity, weight loss, mortality rate, (ii) lipid peroxidation level, nitrite level, and catalase activity in the hippocampus after SE induced by pilocarpine (PC)." | 3.88 | Anticonvulsant effect of argan oil on pilocarpine model induced status epilepticus in wistar rats. ( Ammouri, H; Bahbiti, Y; Berkiks, I; Bikjdaouene, L; Chakit, M; Hessni, AE; Mesfioui, A; Nakache, R; Ouichou, A, 2018) |
| " We found that in the mouse pilocarpine model of status epilepticus (SE), systemic administration of TG6-10-1 completely recapitulates the effects of conditional ablation of cyclooxygenase-2 from principal forebrain neurons, namely reduced delayed mortality, accelerated recovery from weight loss, reduced brain inflammation, prevention of blood-brain barrier opening, and neuroprotection in the hippocampus, without modifying seizures acutely." | 3.79 | Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation. ( Dingledine, R; Dudek, FE; Ganesh, T; Jiang, J; Pouliot, WA; Quan, Y, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahbiti, Y | 1 |
| Ammouri, H | 1 |
| Berkiks, I | 1 |
| Hessni, AE | 1 |
| Ouichou, A | 1 |
| Nakache, R | 1 |
| Chakit, M | 1 |
| Bikjdaouene, L | 1 |
| Mesfioui, A | 1 |
| Jiang, J | 1 |
| Quan, Y | 1 |
| Ganesh, T | 1 |
| Pouliot, WA | 1 |
| Dudek, FE | 1 |
| Dingledine, R | 1 |
| Blazsek, J | 1 |
| Varga, G | 1 |
3 other studies available for pilocarpine and Weight Loss
| Article | Year |
|---|---|
Anticonvulsant effect of argan oil on pilocarpine model induced status epilepticus in wistar rats.
Topics: Animals; Anticonvulsants; Catalase; Diet; Disease Models, Animal; Hippocampus; Lipid Peroxidation; M | 2018 |
Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.
Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Brain; Disease Models, Animal; Hippocampus; Humans; I | 2013 |
Secretion from minor salivary glands following ablation of the major salivary glands in rats.
Topics: Amylases; Analysis of Variance; Animals; Drinking; Female; Follow-Up Studies; Muscarinic Agonists; P | 1999 |